Alternative NewsVaccine News

Pfizer, BioNTech launch first COVID-19 vaccine trial for pregnant women

Pfizer, BioNTech launch first COVID-19 vaccine trial for
pregnant women 1

(5 NEWS ONLINE) – Drugmaker Pfizer and German partner BioNTech have begun a nine-country study of the safety and effectiveness of their COVID-19 vaccine in pregnant women.

The companies said Thursday that the first volunteers have received shots in the study, which is to enroll about 4,000 healthy pregnant women aged 18 and older. Women in the United States, Canada, Argentina, Brazil, Chile, Mozambique, South Africa, Spain and the UK will be included.

Dr. William Gruber, Pfizer’s head of vaccine clinical research and development, said in a statement that “pregnant women have an increased risk of complications and developing severe COVID-19,” and “it is critical that we develop a vaccine that is safe and effective” for them.

Read the full story ›

Read the Full Article

Prepare Now Before its too Late

Discover where products are available & compare prices

Capitol Police Suspends 6 Officers, Investigates Dozens More After Capitol Riots

You might also like
Menu